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Electronic DuraMaterMeddling
in the Central Nervous System
Jocelyne Bloch, MD; Stéphanie P. Lacour, PhD; Grégoire Courtine, PhD
T he central nervous system (CNS) is themost sophisticatedorgan of the human body—orchestrating vegetative, mo-tor,andcognitivebehaviors involved indaily living.Thiscon-
trol center is equipped with a battery of protections against me-
chanical aggression, viral attacks, chemicals, andcerebrospinal fluid
(CSF) leakage.
Theduramater is the toughestbodyguard.Thisoutermost layer
of the meninges confers a mechanical and structural protection to
the CNS. Below the duramater, the arachnoidmater is a fragile and
thin layer thathosts thevessels andseals theCSFcompartment.The
most extensive and softest layer is the pia mater, which conforms
to thecircumvolutionsofnervous tissuesandprovides thebrainand
spinal cordwith their shinyappearance. Finally, theblood-brainbar-
rier establishes a firewall protecting theCNS fromundesirable toxic
or infectious attacks. The blood-brain barrier forms a network of
tightly interconnected endothelial cells that constitute a highly se-
lective,permeablebarrier isolating thecirculatingblood fromtheex-
tracellular matrix and CSF.
Although neurosurgeons and neurologists recognize the cru-
cial role of the meninges and blood-brain barrier in protecting the
CNS, they daily transgress these guardians to treat patients. Neu-
rosurgeons routinelyopen themeninges to removebrain tumorsor
clip aneurysms and meticulously seek to repair these protective
membranes to avoid CSF leakage and infections. Neurologists and
neuro-oncologists continuously seek newmolecules that cross the
blood-brain barrier to treat neuropathologic disease. Through dif-
ferent angles, thesephysicians share thecommongoal of establish-
ing new strategies to meddle in the intimate structures of the CNS
to deliver next-generation treatments.
Electronic DuraMater and Next-Generation Neural Implants
Electronic duramater (e-dura) implants are a novel class of soft yet
resistant neural interfaces thatmimic themechanical properties of
the dura mater.1 The implants are fabricated in a transparent sili-
cone substrate. The leads are made of elastic thin metal films2 or a
metal that is liquidatbody temperature.3Theelectrodesare coated
with a compliant platinum-silicone composite4 that transmits elec-
trical stimulation and transfers electrophysiologic signals. More-
over, the silicone embeds a compliant fluidicmicrochannel termed
a chemotrode that delivers drugs locally. Consequently, every con-
stituent of e-dura is stretchable (Figure 1A). Themechanicalmatch
between the silicone and dura mater confers e-dura with unprec-
edentedbiointegration in theCNS (Figure 1B-C). Long-term implan-
tation of e-dura over spinal tissues does not upregulate activated
astrocytes and microglia. Instead, these standard cellular markers
for foreignbodyreactionweremarkedlyupregulated inanimalswith
implantsconsistingofpolyimide-based thin films.Bothcell typesac-
cumulatenear these stiff implants, causingmacroscopicdamageof
the spinal cord structures.
The e-dura implants thus embody the ideal benevolent “secret
agent” that infiltrates the CNS gently and discretely, with the
mission to read from andwrite into the CNS through electrical and
IMPORTANCE A growing number of neurologic treatments rely on neural implants capable of
delivering electrical and chemical stimulation to targeted regions of the central nervous
system for extended periods.
OBJECTIVE To assess the potential of a novel class of multimodal neural implants, termed
electronic dura mater or e-dura, to fulfill this need.
EVIDENCE REVIEW Results from preclinical applications of e-dura implants and clinical
evidence.
FINDINGS The silicone-based implant e-dura embeds interconnects, electrodes, and
chemotrodes that are entirely stretchable. These uniquemechanical properties allow e-dura
to conform to the circumvolutions of the brain and spinal cord without damaging neural
tissues or triggering foreign body reactions.
CONCLUSIONS AND RELEVANCE Although challenges lie ahead to reach clinical fruition, the
uniquemechanical properties and integratedmodalities of e-dura provide future
opportunities to treat or alleviate neurologic deficits.
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chemical communication channels. For example, e-dura has been
implantedover themotor cortexof rats todecodecortical statesun-
derlying locomotion.1 This interface has also been inserted into the
subdural spaceof lumbar segments todeliver electrochemical neu-
romodulation therapies that restored locomotion inparalyzed rats.5
In both applications, e-dura exhibited reliable functionality over
extended periods.
The translation of this technology into clinical implants faces a
series of challenges. These hurdles notably include compliance of
all the constituents with regulatory requirements, development of
reliable implants for a duration of use that is compatible with hu-
manmedicaldevices,and interfaceofe-durawith implantablestimu-
lation and recording electronics. While we are tackling these tech-
nical challenges, we have imagined clinical applications wherein
e-dura could be used by physicians to treat and alleviate neuro-
logic deficits.
Meddling in the Spinal Cord
Pain Therapies
Epidural electrical stimulationof the spinal cordhasbecomeacom-
monmedical practice to alleviateneuropathicpain resistant to clas-
sic therapies.6Theelectrical current elicits apleasant sensation that
blocks thebrain’s ability toperceivepersistentpain sensations. This
treatment allows patients to reduce analgesic medication use and
thus improves their quality of life. The more severely affected pa-
tientswithchronic intractablemechanical painorpronouncedspas-
ticity benefit from the additional intrathecal delivery of morphine
derivatives or spasmolytic drugs into the intrathecal space through
a catheter attached to an implantable electronic pump.7
Themultimodalpropertiesofe-durasupport thedeliveryofelec-
trical and pharmacologic neuromodulation therapies through the
samemedical device that establishes an intimate interfacewith spi-
nal tissue. Compared with implants located above the dura mater,
the location of the e-dura over the pia mater improves stimulation
Key Points
Question What are the advantages and possible applications of
the soft, multimodal neural interface electronic dura mater?
Findings Soft neural interfaces limit chronic central nervous
system inflammation and conform to the surface of the brain and
spinal cord. In this preclinical review, the ability to stimulate and
record from the same device was found to offer a range of clinical
applications, especially when neuromodulation therapies need to
be applied in poorly accessible regions or when the therapy can be
titrated based on neural activity recordings.
Meaning The soft neural interface electronic dura mater provides
new therapeutic options to treat or alleviate neurologic disorders.
Figure 1. Technical Features of the Electronic DuraMater (e-Dura) Implant
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A, Photograph of the e-dura implant
tailored for spinal cord repair
interventions. The silicone-based
membrane combines soft electrodes
and amicrofluidic channel termed
the chemotrode. Inset shows a
close-up view of in situ drug delivery
(droplet diameter, 2 mm). B,
Cross-section of the subdural e-dura
implant surgically inserted on the
surface of the spinal cord 6 weeks
after implantation. C, Reconstructed
3-dimensional microcomputed
tomography scan of the e-dura
implant in the spinal canal at 5 weeks
after implantation. Adapted in part
fromMinev et al.1
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specificity and allows a substantial decrease in the amount of cur-
rent that is necessary to mediate therapeutic effects.1 This feature
enhancesthe lifeof thebattery, supportingthedevelopmentofmore
ecological pulse generators thatmayplay a crucial role in augment-
ing the patient’s acceptance of implanted devices.8 Moreover, the
chemotrode provides the opportunity to deliver morphine or ba-
clofen through the samemedical device, thus reducing thecost and
complexity.
ImprovingMotor Control After Spinal Cord Injury
Spinal cord damage interrupts the communication between supra-
spinal centers and lumbar spinal circuits that produce leg move-
ments. Albeit intact, lumbar spinal circuits lack the essential source
of modulation and excitation originating from brainstem centers9
to sustain walking.10 Neuromodulation approaches have been de-
veloped to replace these missing inputs. For example, the combi-
nation of serotoninergic agonists and electrical stimulation of lum-
bar segments restored locomotion in rats with a complete injury.10
Electrical stimulation also reactivated lumbar spinal circuits in pa-
tients with paraplegia.11,12
These observations prompted us to study the interactions be-
tweenthis stimulationandspinal circuits forclinical applications.Pre-
vious studies13,14 found that the stimulation engages spinal circuits
through the modulation of proprioceptive feedback circuits lo-
cated in the dorsal roots. This framework guided the design of
e-dura implants that integratedspatially selectiveelectrodes.These
electrodes target thedorsal rootsprojecting tospinal segments that
contain the circuits that produceextensionvs flexionmovements.5
Thee-dura implantswerepositioned subdurally,whichenabled the
concurrent delivery of electrical and chemical stimulation.1 Real-
timecontrolof stimulationnotonlyactivatedbutalsocontrolled the
activity of spinal circuits engaging synergisticmuscle groups.5 Spa-
tiotemporal neuromodulation therapies improved gait quality, en-
durance, andskilled locomotion.5Theseconceptsaredirectly trans-
latable to strategies to improvemotor control in humans.
Meddling in the Brain
The management of neurogenic pain brings a flurry of challenges.
Pharmacologic therapies often show limited efficacy.7 Motor cor-
tex stimulation delivered over the epidural surface has emerged as
a potential strategy to treat resistant peripheral and central neuro-
genicpain resulting fromstrokeor trigeminal neuropathy.15 Imaging
studies16 suggest thatmotor cortex stimulation inhibits thehigh fir-
ing rate of the sensory compartment of the thalamus and increases
the activity of the cingulate gyrus, which together diminish pain.
In present applications, electrodes are positioned epidurally.
Compared with subdural electrode placement, this location pre-
vents arachnoiditis andmitigates complications. However, this ap-
proachhas2majordrawbacks. First, brainatrophy increases thedis-
tance between electrodes and targeted cortical regions. Analgesic
effects require larger electrical currents, which disrupt nontar-
geted regionsand thuselicit adverseeffects. Second, the interhemi-
spheric region is not accessible fromtheepidural surface,whichhas
restricted the application of motor cortex stimulation to the re-
gions of the face and upper limbs.17
The unique biomechanical properties of e-dura afford an inti-
mate apposition of soft electrodes in the vicinity of cortical tissue
while preventing inflammation or venous mechanical shearing
lesions.Previous studies18described theadvantagesof subdural im-
plants for motor cortex stimulation but also revealed higher com-
plication rates. The insertion of e-dura in the interhemispheric re-
gionallowstargetingof the legarea that is currently inaccessiblewith
epidural stimulationwhile potentially reducing nondesired effects.
For example, e-dura can be easily slid below the dura mater with-
out damaging tissue or triggering foreign body reaction.1 Stimula-
tions revealed that e-duramoves togetherwithneural tissue,which
contributes to the long-term biointegration.
Novel Therapeutic Missions
The secret agent e-dura can be inserted below the dura mater in-
cognito.This camouflagedprogrammablemembranecan read from
and write into the CNS through electrical and chemical communi-
cationchannels.These featuresprovidee-durawitha rangeof thera-
peuticmissions.Tounderstand thispotential,wehave identified the
following 4 capacities in the fight against neurologic disorders: (1)
the scout, which explores conflict zones in the brain and provides
this information to ground troops (ie, therapeutic agents to regu-
late brain activity); (2) the hacker, which extracts the patient’s in-
tention from neural signal decoding to control of a lost or an im-
paired function; (3) the firefighter, which extinguishes anarchic
behaviors in the brain; and (4) the strategist, which acts for longer
periods to reprogram brain functions (Figure 2).
The Scout
Deep brain stimulation (DBS) of the subthalamic nucleus is a com-
mon medical practice to alleviate motor and behavioral impair-
ments associated with neurologic disorders such as Parkinson dis-
ease, dystonia, essential tremor, obsessive-compulsive disorder
(OCD),orevendepression.19Morethan90clinical trialshaveprobed
the ability of DBS to treat neurologic diseases.19 Clinical studies
showed that the stimulation variables not only differ between ana-
tomical targets and therapeutic applications but also from patient
to patient. Physicians tune the locations and variables of stimula-
tionempiricallybasedonvisual observations.After titration, thepa-
tienthasvery limitedcontrol over stimulation features. Theamount
of injectedenergy isnotadapted to thestateofpathogeniccircuits.8
This approach fails to exploit the full potential of these interven-
tions. Instead, closed-loop control systems based on detection of
pathologic neural activity could titrate therapies to meet dynamic
patient-specific needs.20 For example, studies in patientswith Par-
kinson disease have shown thatmotor impairments correlate with
the subthalamic nucleus activity in the beta frequency band (13-30
Hz).Thepowerof thisbandhasbeenexploitedtocontrol theamount
of delivered current.21 This closed-loop control policymediated su-
periormotor improvements comparedwith continuous or random
stimulation.Exaggeratedcouplingbetweenthebeta rhythmandthe
amplitudeofbroadbandmotor cortex activity is an alternative con-
trol signal for this application.22
These resultsprovideaglimpseat theexciting future: anewera
of precision neuroprosthetics. The one-size-fits-all DBS technol-
ogy is on the track to obsolescence. Next-generation neuromodu-
lation therapies couldexploit e-dura implants thatare tailored to the
surface and geography of a targeted cortical region to record neu-
ral states. The e-dura implant is more pliable and better conforms
to the gyri and sulci of the brain. This property is likely to enable in-
trasulcal electrocorticography with minimally invasive neurosurgi-
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cal protocols.23 Such e-dura implants would act as scouts that sur-
vey circuitopathy to optimize stimulation variables that normalize
neural states (Figure 2A).
This approachmay translate to various neurologic and psychi-
atric disorders. For example, OCD affects 2% to 3% of the popula-
tion. Peoplewith OCD exhibit recurrent intrusive thoughts (obses-
sions), repetitive behaviors, and/or mental acts (compulsions)
triggered by anxiety. Obsessive-compulsive disorder was initially
linked to altered corticostriatal circuitry, but recent neuroimaging
studies24uncoverednetworksof interlinkedneuronal systems inpa-
tientswithOCD. The emergence of symptomshas been associated
withexcessiveprefrontalactivity.24NucleusaccumbensDBS isapos-
sible strategy toalleviatemedically resistantOCD.19Thenucleus ac-
cumbens interfaces the limbic andmotor systems. The stimulation
thus aims at regulating the disrupted integration of emotional and
motor information in thenucleusaccumbens.Atpresent, the stimu-
lation isdeliveredcontinuously.Apotentiallymoreefficacious strat-
egy may exploit e-dura implants to detect abnormal neuronal ac-
tivity fromprefrontal recordingsandtriggernucleusaccumbensDBS
on demand to diminish the amplitude or even prevent the onset of
compulsions and obsessions.
The Hacker
The e-dura implants could help the brain deliver commands to dis-
rupted circuits or paralyzed limbmuscles. Similar to a hacker med-
dling in a computer program to take control of its operations
(Figure 2B), e-dura can crack the neural code to detect motor
intentions.1,25
Thee-dura implant canbepositionedover the leg regionof the
motor cortex, which is located in the interhemispheric fissure. This
location is difficult to access using rigid implants. Legmotor cortex
signals allow decoding of gait initiation or gait timing,1 which pro-
vides high-level commands to steer locomotor prosthetics.26 This
decodingmay directly adjust spinal cord stimulation to reestablish
legmovements afterparalysis.27When implantedover thearmmo-
tor cortex region, e-dura could support the design of a brain-
computer interface that links intended hand movements to com-
puters, prosthetic limbs, or armmuscle stimulation.28,29
The Firefighter
Thee-dura implant could serveas a firefighter that extinguishes an-
archic brain behaviors, such as epileptic seizure (Figure 2C). Al-
thoughthisneurologicdisorder isgenerallywell controlledwithmedi-
cation, epilepsy is refractory to pharmacotherapy in 20% to 30%
ofpatients.Whenmedically intractable seizuresemerge fromawell-
defined, noneloquent region, ablative surgery of the epileptic fo-
cus provides an efficient strategy to treat these patients. Neuro-
modulation therapies, includingvagal nerve stimulationor thalamic
DBS, are theonlyalternative strategies forpatientswhoarenot can-
didates for ablative surgery.
Figure 2. Different “Secret-Agent” Roles of Electronic DuraMater (e-Dura)
ScoutA HackerB
FirefighterC StrategistD
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The e-dura implant (cyan) can read
from and write into the central
nervous system using electrodes and
chemotrodes (purple) to treat
neurologic disorders. As the scout,
e-dura reads the neural state to
adjust deep brain stimulation
therapies to the current need of the
patient. As the hacker, e-dura reads
motor intention from cortical
ensemble modulation (illustrated for
handmovement). As the firefighter,
e-dura detects the onset of an
epileptic episode and delivers
electrical and chemical stimulation to
extinguish the seizure. As the
strategist, e-dura delivers stimulation
over an eloquent region of the brain
to encourage adjacent regions to take
over its function, thus allowing the
preservation of speech abilities after
removal of the brain tumor in the
targeted region.
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Recently, NeuroPace received a premarket approval from the
USFoodandDrugAdministration for a closed-loopdevice that con-
trols medically refectory seizures. This device integrates leads tar-
geting the surface of the cortex and deep structures overlying the
preidentified epileptic foci. The NeuroPace system automatically
senses abnormal neural activity and responds to emerging sei-
zureswithelectrical shocks that stoptheseizure.Adouble-blind ran-
domized clinical trial30 reported that NeuroPace decreased mean
seizure frequency by 37.9%. A reduction of the delay between sei-
zure detection and electric shock delivery could enhance the effi-
cacy of this treatment. Indeed, the key feature of this strategy is to
trigger the electric shock before the spread of the epileptic wave.
The e-dura implants present several advantages in this fire-
fight.Thismembranecancovera largecortical surface, integratedoz-
ensofelectrodes toprovidehigh-level territory surveillance, and fire
electrical shocks over multiple regions simultaneously or sequen-
tially. However, this type of implant will require multichannel con-
nectors, amplifiers, and other complex electronics that are still un-
der development.31 Moreover, e-dura the firefighter can integrate
a second lineofdefense. Themicrofluidic channels enable the rapid
infusion of antiepileptic drugs at the specific sites of fire. For ex-
ample, the local cortical infusionofγ-aminobutyric acidagonistshas
mediatedanticonvulsiveeffects in animalmodels of epilepsy.32 The
local applicationallows thedrug to reachahighconcentrationat the
target site, whileminimizing the secondary adverse effects associ-
ated with systemic administration.
The Strategist
Asuddenneurologic insult opens awindowofopportunity for neu-
roplasticity,whichmediatespartial recoveryof affectedbodily func-
tions.Consequently, thedevelopmentof strategies toaugmentneu-
roplasticity remains a major challenge and priority in public health
policies.
Neuromodulation therapies showedtheability topromoteana-
tomical and structural reorganization of neural pathways. For ex-
ample, long-lastingstimulationofcorticospinalaxonsafterspinalcord
injury triggered a sprouting of synaptic terminals in the brainstem
and spinal cord.33,34 This remodeling enhanced motor recovery in
animal models. Similarly, repetitive transcranial magnetic stimula-
tion and transcranial direct current stimulation enhanced motor
learning and cognitive recovery in persons with stroke.35,36
These treatmentsusenoninvasive techniques thatnotonly lack
specificitybutalsorequirespecialistswhodeliver thestimulationdur-
ing succinct sessions scattered across severalweeks. The strategist
properties of e-dura are uniquely fitted to improve these ap-
proaches. The implantation of e-dura over targeted cortical re-
gionsenablesdeliveryof long-termstimulation,which is likely to lead
to more pronounced improvements compared with intermittent
stimulations. Moreover, the practicality of implantable technology
enhances the spectrum of possible combinatorial therapies. Elec-
trical stimulation patterns can be synchronized with virtual reality
environments, robotic actuation, andsensoryenhancement toaug-
ment the cognitive, motor, and sensory rehabilitation experience.
The rapiddevelopmentofbioresorbable electronics37mayevenof-
fer the additional advantage of limiting this strategy to a single sur-
gical intervention.
Removal of aglioma fromadominant cerebral hemispheremay
endanger critical brain functions, including the understanding and
productionof language.Aggressivegliomas lead to irreversible loss
of functionsencoded inthe invadedregion. Instead, longitudinalneu-
roimaging studies revealed that, when gliomas grow slowly, sur-
rounding brain territories progressively take over the operations of
invaded regions,which results in unexpectedpreservation of func-
tion. On one hand, this vicarious potential of surrounding brain tis-
sues conflicts with the primary strategy of neurosurgeons, which
consists of maximizing total gross tumor resection. On the other
hand, thisneuroplasticitycanbeexploitedtopreservefunctions.This
awareness has triggered the development of staged surgical treat-
mentswherebygliomasare removedduringawakesurgeryuntil ap-
proaching eloquent areas. A second surgical resection is per-
formed several months later when neuroplasticity has occurred in
surrounding tissues.
In the ideal scenario, the neurosurgeon would implant a neu-
romodulationdeviceduring the first resection toaccelerate theshift
of the eloquent area and thus reduce the interval between the ab-
lation procedures. In the strategist application, e-dura could em-
power neurosurgeons with the weapon tomake this strategy a re-
ality (Figure 2D). A case study reported that high-frequency
stimulation applied for 25 days over the surface of a partially re-
sected tumor located in theBroca areaproducedamild speechdis-
turbance that forcedthebrain toshift the locationof thespeecharea
away from the stimulation.38 Therefore, shortly after the first par-
tial resection, a second,more radical resection could be performed
without altering the speech abilities of the patient. The versatility
of e-dura implants is well suited for this application. Moreover,
e-dura provides the opportunity to infuse chemotherapies locally
to reduce the growth of the tumor.
Conclusions
We sought to provide a glimpse of the exciting therapeutic oppor-
tunities that next-generation implant technology, such as e-dura,
may provide for the diagnosis and treatment of neurologic disor-
ders. This technology heralds precision neuroprosthetics.
Although challenges lie ahead to pass the various regulatory
hurdles and technical issues along the path to clinical fruition, we
believe that the pluripotent secret agent e-dura will provide a
novel arsenal to help neurologists and neurosurgeons meddle in
the intimate and hidden territories of the brain and spinal cord to
treat or alleviate neurologic deficits and thus improve a patient’s
quality of life.
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